Navigation Links
Teens Divulge Risky Behavior on Social Networking Sites
Date:1/5/2009

But e-mail intervention may spur some adolescents to change, study finds,,

MONDAY, Jan. 5 (HealthDay News) -- More than half of teens who use the social networking site MySpace have posted information about sexual behavior, substance abuse or violence, new research shows.

The good news, according to a second study from the same research group, is that a simple intervention -- in this case, an-e-mail from a physician -- made some of the teens change their risky behaviors.

"I was surprised, at least to some extent, at how clearly teens were discussing behaviors that we struggle to get out of them," said Dr. Megan Moreno, an assistant professor of pediatrics at the University of Wisconsin-Madison.

"Once we started getting the findings, we wondered, why are they doing this?" Moreno said. "Do they not get it? And, if they don't understand that this is public, can we send them a cautionary message to let them know just how public their information really is?" Moreno was working at the University of Washington and Seattle Children's Research Institute at the time the studies were done.

"We need to devise ways to teach teens and their parents to use the Internet responsibly," study senior author Dr. Dimitri Christakis, director of the Center for Child Health, Behavior and Development at Seattle Children's Research Institute, said in a statement.

Results from the two studies appear in the January issue of the Archives of Pediatric and Adolescent Medicine.

More than 90 percent of teens in the United States have access to the Internet, according to background information from the studies. About half of all teens who use the Internet also use social networking sites, such as MySpace and Facebook. MySpace boasts more than 200 million profiles, according to the studies, and about one-quarter of those belong to teens under 18.

Moreno and her colleagues randomly selected 500 MySpace
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Car Key Device Jams Teens Cell Phones
2. Rejection of Gay Teens Linked to Later Troubles
3. Gastric Bypass Halts Diabetes in Obese Teens
4. Many Teens Dont Keep Virginity Pledges
5. Usher Teams With Body By Milk to Give Teens Once-in-a-Lifetime Opportunity
6. Later School Start Time Cuts Teens Car Crash Risk
7. Obesity among states low-income teens nearly triple that of more affluent peers
8. Report Finds Fault With U.S. Health Services for Teens
9. Laws Governing Indoor Tanning by Teens Dont Work
10. Self-Embedding a Troubling Trend Among Teens
11. Radiologists diagnose and treat self-embedding disorder in teens
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Teens Divulge Risky Behavior on Social Networking Sites
Teens Divulge Risky Behavior on Social Networking Sites
(Date:7/2/2009)...sing Technology Institute (BTI) have made a novel ...itory molecule" (FAIM), protects both immune and l...h. , Their research is published in the current... scientists, Jianxin Huo, Ph.D., and Shengli Xu, P...ly be manipulated for clinical application and pro...
(Date:7/2/2009)...swire/ -- Pro-life forces won an important battle ...old a state law regulating that abortion centers m...g RU-486 (also known as the "abortion pill") in or... , , The ruling came in Rogers v. Planned Par...004 law requiring that those administering RU-486 ...
(Date:7/2/2009)...e threat, expert says , , THURSDAY, Jul...o certain species of wildlife, which need to be pr.... , "Cancer is one of the leading health concer... of human deaths. But we now understand that cance...thor Denise McAloose, chief pathologist for the Wi...
(Date:7/2/2009)...issues need to be addressed in order to improve bi...er, according to a commentary published online Jul...te . , The biomarker pipeline to develop and eva...cation of promising biomarkers to detect cancers e...biomarkers for cancer screening. , In the comme...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Cancer Endangers Some Wildlife Species 2
...n India have initiated a unique project that aims ...hants through mobile clinics. // Conceptualised b...cob V. Cheeran, the project is supported by two Ba...tion Foundation (ANCF) and Compassion Unlimited Pl...
...n do not keep up their appointment for breast canc...mmogram appointment.// A report has shown that ou...screening, less than 60,000 women actually turned ...eila Caulfield of BreastCheck said 'It's an unusua...
...ration of U.S has chalked out a seemingly fool pro...fety //and efficiency of medical gadgets that are ...ents requiring them for various medical reasons. T... the market today in the U.S accounts for a whoppi...
...y, mice die early when exposed to time shifts simu...ng unusual // shifts and flying across time zones ...n that older humans shorten their lives by flying ... the research does suggest there might be a potent...
Other Medicine News:Health News:Free health check-ups for captive elephants 2Health News:Novel Plans Of FDA To Monitor Safety Of Medical Devices 2Health News:Jet Lag May Cause Health Problems: Study 2
(Date:7/1/2009)..., Denmark, July 1 A just...ion on Investigational Drugs", Volume,18, Issue 7... on,PROSTVAC(TM). This is the most comprehensive ... Quote from the article: "Preliminary clinical t...se II trials have suggested a survival benefit,af...
(Date:6/30/2009)...e 30 Accumetrics, Inc. announces t...s) in the enrollment of its landmark clinical tria...erifyNow(R) Assay I mpact on T hrombosis A nd ...emonstrate the value of providing clinicians with ...esponders to clopidogrel (Plavix(R)). The multi-c...
(Date:6/30/2009)... The Netherlands, June 30 , ...Making Process With,Respect to Infertility Treatm...resented today at this year,s,European Society of...s showed,that, within the parameters of the simul...) treatment MENOPUR (highly-purified human menopau...
(Date:6/29/2009)... abdominal surgery patients achieved primary and s...ne 29 AcelRx Pharmaceuticals, Inc....Phase 2 clinical study evaluating the safety and e...the management of acute post-operative pain in pat...ation. Compared to placebo, patients receiving ARX...
Breaking Medicine Technology:New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4New Canadian study finds drug coated heart stents to be safe 3A 2825 1New Canadian study finds drug coated heart stents to be safe 3A 2825 2New Canadian study finds drug coated heart stents to be safe 3A 2825 3New Canadian study finds drug coated heart stents to be safe 3A 2825 4Solazyme Announces New Senior Vice President of Business Development 1033 1Solazyme Announces New Senior Vice President of Business Development 1033 2Presidents Veto of Childrens Health Bill Marks First Round in National Fight About Health Care 2820 1Mediware Information Systems Inc Receives Notice from the Nasdaq Stock Market 2816 1Mediware Information Systems Inc Receives Notice from the Nasdaq Stock Market 2816 2
...us Minocycline Showed Substantial,Reduction of Dis...mitting Multiple Sclerosis , Combination Treatment... Was Well Tolerated , KANSAS CITY, Mo, May 4, 2007...showed that a combination of Copaxone,(glatiramer ...minocycline reduced T1 Gadolinium (Gd)-enhancing l...
...S WIRE)--May 4, 2007 - Lux Biosciences,Inc., a pr...the,field of ophthalmic diseases, announced today ...ibitor, LX211, is the subject of two,presentations...thalmology (ARVO) annual meeting, being held May 6...al presentation being given on May 5 during a,sate...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4
HydroExpression Cannula - Corydon
J Hydrodissector
Hydrodissector
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)
Medicine Products: